According to Nektar Therapeutics 's latest financial reports the company's current revenue (TTM) is $90.12 M. In 2022 the company made a revenue of $92.05 M a decrease over the years 2021 revenue that were of $0.10 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $90.12 M | -2.1% |
2022 | $92.05 M | -9.67% |
2021 | $0.10 B | -33.36% |
2020 | $0.15 B | 33.41% |
2019 | $0.11 B | -90.4% |
2018 | $1.19 B | 287.81% |
2017 | $0.30 B | 86% |
2016 | $0.16 B | -28.31% |
2015 | $0.23 B | 14.99% |
2014 | $0.20 B | 34.77% |
2013 | $0.14 B | 83.42% |
2012 | $81.19 M | 13.59% |
2011 | $71.48 M | -55.06% |
2010 | $0.15 B | 121.1% |
2009 | $71.93 M | -20.24% |
2008 | $90.18 M | -66.97% |
2007 | $0.27 B | 25.4% |
2006 | $0.21 B | 72.41% |
2005 | $0.12 B | 10.51% |
2004 | $0.11 B | 7.54% |
2003 | $0.10 B | 12.03% |
2002 | $94.84 M | 22.43% |
2001 | $77.46 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $93.02 B | 103,117.86% | ๐บ๐ธ USA |
Pfizer PFE | $58.49 B | 64,808.68% | ๐บ๐ธ USA |
Amgen AMGN | $28.19 B | 31,179.82% | ๐บ๐ธ USA |
Baxter BAX | $14.94 B | 16,487.51% | ๐บ๐ธ USA |
Merck MRK | $60.11 B | 66,602.91% | ๐บ๐ธ USA |
AstraZeneca AZN | $45.81 B | 50,732.21% | ๐ฌ๐ง UK |
Richardson Electronics RELL | $0.22 B | 150.67% | ๐บ๐ธ USA |
Alkermes ALKS | $1.66 B | 1,745.73% | ๐ฎ๐ช Ireland |